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AbstrACt
Objectives This study explored the relationship between 
self-management and blood pressure (BP) control in China.
Design A cross-sectional study.
setting Eight community health centres from four cities 
in the Northeast (Shenyang), Northwest (Xi’an), Southwest 
(Chengdu) and South (Changsha) of China.
Participants A total of 873 adults with hypertension, 
including 360 men and 513 women. Hypertension was 
defined as systolic BP ≥140 mm Hg and/or diastolic BP 
≥90 mm Hg.
Outcome measurements BP control was the primary 
outcome variable. This was categorised as good control 
if individuals with hypertension reduced their BP to 
<140/90 mm Hg, otherwise, it was categorised as poor 
control. Secondary outcomes included self-management, 
defined as: (1) context or condition-specific factors or 
physical/social environments (eg, age, sex, marital status, 
education, personal income and health insurance) and 
(2) process or knowledge/beliefs, self-regulation skills/
abilities and social facilitation (eg, treatment, diet, exercise 
and risk factor management). Data were analysed using 
logistic regression models using SPSS V.20.
results A total of 67.1% (n=586) participants had poor 
BP control. Limited outpatient care benefits in mainly 
rural residents (OR 2.26, 95% CI 1.06 to 4.81) and longer 
disease duration (OR 1.03, 95% CI 1.01 to 1.04) were 
associated with poor BP control. Self-management 
practices reduced the odds of having poor BP control (OR 
0.98, 95% CI 0.97 to 0.99).
Conclusions The individual and family self-management 
theory can serve as an effective theory for understanding 
the key contexts, processes and outcomes essential for 
BP control in China. Future research should evaluate 
the effect of a self-management intervention (eg, self-
monitoring, medication adherence, regular and routine 
doctor visits, and social supports) for BP control in China 
using a multisite cluster randomised controlled trial. Sex 
and gender difference, cost and patient-reported outcomes 
should also be examined.
bACkgrOunD   
The prevalence of hypertension has 
increased worldwide.1 It is the most signif-
icant risk factor of cardiovascular disease 
(CVD), accounting for nearly half of the 
cardiovascular morbidity and mortality in the 
world.2–5 In China, hypertension is a serious 
public health problem; it has increased 
almost 400% from 1980 to 2015 (from an 
estimated 59 million to 244.5 million)6–8 and 
has accounted for over 2 million deaths or 
24.6% of all-cause mortality.9 Hypertensive 
complications in China are similar to other 
countries, which include stroke, myocardial 
infarction, heart failure and chronic kidney 
disease.10 Stroke is the leading cause of 
death and disability in China with an annual 
mortality of 1.6 million11; hypertension is the 
most important risk factor for stroke with the 
highest attributable risk at 34.6%.11 Annual 
stroke healthcare expenditures are approxi-
mately￥40 billion (US$6.4 billion), causing 
a huge burden to the Chinese economy.11 
Domestic and international research studies 
have proved that adequate control of blood 
pressure (BP) reduces stroke,12 CVD13 and 
burden of disease,14 15 and significantly 
improves health-related quality of life 
(HRQOL).16 17 
The Chinese government launched the 
Chinese Basic Public Health Service Program 
in 2009; this provides a package of care that 
includes hypertension and diabetes screening 
and management in various community 
strengths and limitations of this study
 ► A strength is the use of the individual and family 
self-management theory to guide the study.
 ► A strength is incorporation of a sex-based analysis.
 ► A strength is an attempt to use a surrogate marker 
of gender in the interpretation of results (level of ed-
ucation, personal income and employment status).
 ► A limitation is the use of the self-management scale 
for patients with hypertension. It has not been widely 
used and requires further psychometric testing.
 ► As this is a cross-sectional study, results are limited 
by self-reported survey questions. Additionally, there 
could be other unobserved confounding factors we 
have neither considered nor controlled.
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healthcare facilities. In 2013, the 17-country Prospective 
Urban Rural Epidemiology study reported hypertension 
awareness of 46.5%, treatment of 87.5% and control of 
32.5%.2 In 2017, the China Patient-Centred Evaluative 
Assessment of Cardiac Events study of 1.7 million individ-
uals with hypertension suggested the prevalence of hyper-
tension in China was 37.2%, with an awareness of 36%, 
treatment of 22.9% and control of only 5.7%.8 These 
results suggest that current governmental packages of 
care are insufficient to address the burden of hyperten-
sion in China.18
Successful self-management strategies for individuals 
can result in effective control of BP.19 20 Many studies 
of hypertension self-management have improved BP 
outcomes in the Western societies,15 21 22 however, the 
evidence for hypertension self-management is absent in 
the Chinese population. A recent systematic review iden-
tified only two quasi-experimental studies focusing on 
hypertension self-management in a population of Amer-
ican Chinese23; much of the evidence was derived from 
a single urban site so is not representative of individuals 
living in community settings.24 25
The individual and family self-management theory 
(IFSMT) suggests a dynamic model of self-management 
consisting of: (1) condition-specific factors and phys-
ical/social environments (context), (2) knowledge and 
beliefs, self-regulation skills and abilities, and social facili-
tation (process), and (3) cost, health status and HRQOL 
(outcomes).26 Self-regulation includes the processes used 
to change behaviour, such as setting goals, self-monitoring, 
reflective thinking, planning/participating in specific 
behaviours, management of responses and self-evalua-
tion.26 Approaches to managing hypertension using the 
IFSMT within the Chronic Care Model27 28 suggest indi-
viduals use self-regulation skills and abilities19 29 30 and 
work in partnership with healthcare providers to improve 
outcomes.31
Sex and gender differences have been gaining atten-
tion in the development and management of hyperten-
sion.32–34 Women are twice as likely to have uncontrolled 
BP after menopause,32 have a higher prevalence of 
obesity35 and are less likely to engage in physical activ-
ities36 compared with men. Although the treatment 
benefit of antihypertensive agents may not differ 
between men and women,37 women with hypertension 
are less likely to achieve recommended BP targets,34 38 
even with significantly higher use of antihypertensive 
medications.34 Sex and gender are distinct concepts 
often used interchangeably in the literature, both are 
important to hypertension prevalence, awareness and 
management.22 35 39 Sex represents the biological charac-
teristics of being male or female and gender represents 
the social norms and expectations ascribed to men and 
women.40 41 Gender differences in women’s self-man-
agement practices are affected by broader social, envi-
ronmental and community factors described as gender 
roles, gender identity, gender relationships and institu-
tionalised gender.42
The aim of this study is to describe context and process 
variables within the IFSMT that impact BP control 
(outcomes) in men and women in China. This includes 
exploring both sex and gender aspects to self-manage-
ment and BP control in Chinese adults living in the 
community.
MethODs
study design and settings
Using a cross-sectional study design, individuals with 
hypertension were recruited from eight community 
healthcare centres in the Northeast (Shenyang city), 
Northwest (Xi’an city), Southwest (Chengdu city) and 
South (Changsha city) of China from April 2015 to 
January 2016. Four geographical areas were chosen in an 
attempt to recruit a representative sample of individuals 
with hypertension in China.
Participants
Recruitment was conducted in four steps. First, forty 
national model community health centres (CHCs) 
accredited between 2011 and 2013 were purposely 
selected from the four cities in China.43–45 These centres 
provide national standardised medical care to more than 
100 000 individuals within a district in each of the four 
cities. Second, two community healthcare centres were 
randomly selected in each city from the forty national 
model community centres using a random number table 
for study participation. Third, 1048 individuals (131 from 
each CHC) who had been screened and diagnosed with 
hypertension within the past 6 months were randomly 
recruited from electronic healthcare information systems. 
Fourth, individuals were contacted to determine their 
interest in participating in a telephone interview to learn 
more about the study.
Individuals who met the following inclusion criteria 
were recruited to participate: age ≥18 years, systolic BP 
(SBP) ≥140 mm Hg and/or diastolic BP (DBP) ≥90 mm 
Hg or prescribed antihypertensive medication for at least 
6 months and able to identify their hypertensive medica-
tions within their medication schedule, able to read and 
write the Chinese language, and able to provide written 
informed consent to participate in the study. Individuals 
were excluded if they were pregnant, had cancer or were 
identified as being cognitively impaired in the health 
record (<recommended a cut-off score of 26 using the 
Montreal Cognitive Assessment Chinese version-Beijing 
version).46
Trained research assistants who followed standard oper-
ating procedures explained the purpose and confidenti-
ality of the study to participants and informed consent 
was obtained prior to survey completion.
Patient and public involvement
Patients and the public were not involved in the design 
of this study.
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Measurement
The IFSMT guided data collection and measurement.26
Context
Demographic (age, sex, marital status, education, 
personal income and health insurance) data were 
collected by interview using investigator-developed ques-
tionnaires. Marital status was divided into two catego-
ries: married or single/divorced/widowed. Education 
was categorised as primary school or no formal educa-
tion (<6 years of schooling), high school (6–12 years of 
schooling) or college or higher (>12 years of schooling). 
Personal income was divided into two categories: ≤￥1500 
(US$225) or >￥1500 (US$225) based on Chinese indi-
vidual income tax rates.47 Health insurance was divided 
into four categories: Urban Employees’ Medical Insurance 
(UEMI), Urban Residents’ Medical Insurance (URMI), 
New Rural Cooperative Medical Scheme (NCMS) and 
uninsured.
Risk behaviours included smoking (smoker (current 
smokers who smoked more than one cigarette daily)) 
or non-smoker (smoked fewer than 6 months or never 
smoked)) and alcohol consumption (consumer or 
non-consumer (consumed less than one glass per month 
or never drank)). Family history of hypertension was 
defined as a blood relative such as mother, father, sister 
or brother with diagnosed hypertension (SBP ≥140 
mm Hg and/or DBP ≥90). Anthropometric measures 
included weight and height (body mass index (BMI)) 
and waist circumference (WC)). BMI was calculated as 
weight in kilograms divided by height in metres squared 
and classified into four levels according to the guidelines 
for prevention and control of overweight and obesity 
in Chinese adults: underweight (<18.5 kg/m2), normal 
(18.5–23.9 kg/m2), overweight (24.0–27.9 kg/m2) and 
obese: (≥28 kg/m2).48–50 WC was divided into two cate-
gories: obese (men ≥90 cm, women ≥80) and normal 
(men <90 cm, women <80 cm) according to the Interna-
tional Diabetes Federation51 and National Institute for 
Health and Care Excellence.52 Comorbidities were self-re-
ported and based on a physician’s diagnosis.
Process
The self-management scale for individuals with hyper-
tension53 used in this study was developed by the China 
Medical Foundation community chronic disease manage-
ment research group. Split-half reliability of the scale was 
0.976 and Cronbach’s alpha ranged from 0.853 to 0.868 
on each of the 5 subscales. The 5 subscales contained 21 
Likert scale items addressing: treatment management, 
diet management, physical exercise management, life-
style management and risk factor management. Subscale 
scores ranged from 1 to 5 and total scores ranged from 
21 to 105, with higher scores indicating higher self-man-
agement behaviours (online supplementary file). In this 
study, original subscale scores were converted to standard 
scores for comparisons.
Outcomes
Blood Pressure: BP control was defined as a good if indi-
viduals had an SBP <140 mm Hg and DBP <90 mm Hg. 
BPs were taken by trained nurses using a mercury sphyg-
momanometer according to the criterion formulated 
by the Chinese Hypertension League/National Centre 
for Cardiovascular Disease.54 Two BP readings for each 
participant were obtained at 2 min intervals in a sitting 
position and then averaged for analysis.
bias
This study is cross-sectional and results may be subject to a 
non-response bias.55 However, recruiting a large number 
of individuals with hypertension across four areas of 
China attempted to minimise this bias. As this is an obser-
vational study, results are limited by self-reported survey 
questions. Additionally, there could be other unobserved 
confounding factors we have neither considered nor 
controlled.
sample size
The sample size was based on 15–30 subjects per predictor 
in the logistic regression model.56 Given there were 22 
predictors, the final sample size was estimated at 660. The 
final sample size was increased to a total of 792 partici-
pants to account for a 20% attrition (n=106 participants 
from each community healthcare centre).
Data analysis
All data were analysed using SPSS V.20. Univariate statis-
tics (frequencies, percentages and means) were used to 
describe the contextual factors of the sample. Bivariate 
associations between context and process variables were 
assessed using X2 and t-tests or Mann-Whitney U tests for 
non-normally distributed outcome variables.
Based on the IFSMT theory, a multivariable logistic 
regression model was used to examine the association 
between context (individual/family, condition specific), 
process (BP self-regulation skills and abilities (treat-
ment management, diet management, physical exercise 
management, lifestyle management, risk factor manage-
ment), CHC visits, hospitals visits) and outcomes (BP 
control). Preliminary steps included assessing for multi-
collinearity using the variance inflation factor. A hier-
archical approach was used to build our final model,55 
starting with model 1, then cumulatively adding clusters 
(models 2 and 3) of variables.
In model 1, the non-modifiable context variables 
related to the individual/family (age, sex, marital status, 
education, employment, personal incomes and health 
insurance) were explored. In model 2, modifiable vari-
ables that were condition specific (BMI, WC, disease 
duration, comorbidities, family history, smoking and 
alcohol consumption) were added to model 1. In model 
3, processes variables related to self-regulation skills and 
abilities (treatment management, diet management, 
physical exercise management, lifestyle management, 
risk factors management, CHC visits and hospitals visits) 
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were added to model 2. Nested models were compared 
using the likelihood ratio test (LRT). Clusters were kept 
in the model if they significantly contributed to model fit 
based on the LRT. A two-sided p<0.05 was used to estab-
lish statistical significance.
results
Twenty-nine individuals refused to participate in the 
interview. Of those who participated, 114 individuals were 
excluded due to cognitive impairment (n=90), pregnancy 
(n=11) and cancer (n=13). Of 905 eligible participants, 32 
were excluded because of missing or implausible (more 
than 50% of the responses) data (figure 1). A total final 
sample of 873 individuals with hypertension (360 males, 
513 females) consented to participate in the study.
Context
Demographic characteristics of participants are 
presented in table 1. The mean age of participants was 65 
years. Most of the samples were female (n=513, 58.8%), 
married (n=757, 86.7%) and retired (n=596, 68.3%). The 
majority of participants had health insurance (n=839, 
96.1%), 10 years disease duration and poor BP control 
(n=586, 67.1%). Most had an abnormal BMI (under-
weight, overweight and obese) (n=569, 65.1%) and WC 
(n=644, 73.8%). Compared with men, more women were 
single/divorced/widowed, less likely to have graduated 
from college, were unemployed and had a lower personal 
income. Women were also more likely to be non-smokers 
and non-drinkers but had more comorbidities compared 
with men.
Process
Self-management process variables are reported in 
table 2. The lowest scores in self-management skills 
and abilities were in treatment management (eg, medi-
cation adherence, routine and regular doctors’ visits, 
self-monitoring BP), physical exercise management, life-
style management and diet management. Scores of risk 
factor management were highest. Compared with men, 
women were more likely to have higher total scores for 
self-management skills/abilities, diet management and 
risk factor management. Women also had more hospital 
visits compared with men.
Outcomes
Results of the logistic regressions analyses are depicted in 
table 3. All models had a good fit based on the Hosmer-Le-
meshow test. In model 1, personal income and health 
insurance were significant for BP control. Participants 
with NCMS (medical scheme mainly for rural residents) 
compared with UEMI (medical insurance mainly for 
urban employees) increased the odds of poor BP control 
(OR 2.70, 95% CI 1.28 to 5.67). When BMI, WC, smoking, 
drinking, family history, disease duration and comorbid-
ities were added into model 2, there was a slightly lower 
odds of NCMS compared with UEMI affecting poor BP 
control (OR 2.69, 95% CI 1.27 to 5.69). A higher odd of 
having poor BP control was also observed with a longer 
duration of disease (OR 1.03, 95% CI 1.01 to 1.04). A 
similar pattern was observed when treatment manage-
ment, diet management, physical exercise management, 
lifestyle management, risk factor management, CHC visits 
and hospital visits were added to model 3. Self-manage-
ment treatments reduced the odds of poor BP control in 
the final model (OR 0.98, 95% CI 0.97 to 0.99).
Figure 1 A flow chart of included and excluded cases. CHCs, community health centres.
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Table 1 Characteristics of community participants with hypertension
Total
(n=873)
Men
(n=360)
Women
(n=513)
P value
Mean (SD)/
n (%)
Mean (SD)/
n (%)
Mean (SD)/
n (%)
Age (years) 65 (9.5) 65 (9.9) 66 (9.2) 0.075
Marriage status <0.001
  Married 757 (86.7) 346 (96.1) 411 (80.1)
  Single/divorced/widowed 116 (13.3) 14 (3.9) 102 (19.9)
Education <0.001
  Primary school or no 183 (21.0) 53 (14.7) 130 (25.3)
  High school 544 (62.3) 232 (64.4) 312 (60.8)
  College or higher 146 (16.7) 75 (20.8) 71 (13.8)
Employment <0.001
  Employed 145 (16.6) 91 (25.3) 54 (10.5)
  Unemployed 132 (15.1) 44 (12.2) 88 (17.2)
  Retired 596 (68.3) 225 (62.5) 371 (72.3)
Personal incomes <0.001
  ≤¥1500 (US$225) 307 (35.2) 94 (26.1) 213 (41.5)
  >¥1500 (US$225) 566 (64.8) 266 (73.9) 300 (58.5)
Health insurance 0.170
  UEMI 636 (72.9) 271 (75.3) 365 (71.2)
  URMI 103 (11.8) 32 (8.9) 71 (13.8)
  NCMS 100 (11.5) 43 (11.9) 57 (11.1)
  Uninsured 34 (3.9) 14 (3.9) 20 (3.9)
BMI
  Underweight 10 (1.1) 2 (0.6) 8 (1.6) 0.377
  Normal 304 (34.8) 120 (33.3) 184 (35.9)
  Overweight 412 (47.2) 178 (49.4) 234 (45.6)
  Obese 147 (16.8) 60 (16.7) 87 (17.0)
WC
  Normal 229 (26.2) 144 (40.0) 85 (16.6) <0.001
  Obese 644 (73.8) 216 (60.0) 428 (83.4)
Smoking status <0.001
  Smoking 239 (27.4) 216 (60.0) 23 (4.5)
  Non-smoking 634 (72.6) 144 (40.0) 490 (95.5)
Drinking status <0.001
  Drinking 196 (22.5) 176 (48.9) 20 (3.9)
  Non-drinking 677 (77.5) 184 (51.1) 493 (96.1)
Family history 0.944
  Yes 533 (61.1) 219 (60.8) 314 (61.2)
  No 340 (38.9) 141 (39.2) 199 (38.8)
Disease duration (years) 10 (9.0) 9 (7.9) 10 (9.7) 0.079
Comorbidities
  CAD 195 (22.3) 75 (20.8) 120 (23.4) 0.370
  Back/neck problem 97 (11.1) 27 (7.5) 70 (13.6) 0.004
  Stroke 96 (11.0) 44 (12.2) 52 (10.1) 0.334
Continued
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DisCussiOn
Context of self-management and bP control
The results of this study provide insights into the contex-
tual self-management factors that impact BP control in 
China. A total of 67.1% of individuals with hypertension 
living in the community did not achieve recommended 
BP targets. Results are consistent with previous studies 
that suggest poor BP control is linked to a lower socioeco-
nomic status.57–60 Individuals with UEMI health insurance 
and benefit packages that covered outpatient services had 
better BP control than those individuals enrolled with 
NCMS (extremely limited outpatient care benefits for 
rural residents).61–63 Inadequate insurance and poor BP 
control is also supported by a US National Health and 
Nutrition Examination Survey.64
Results from this study also suggest that longer disease 
duration increases the odds of having poor BP control. 
This is consistent with a cross-sectional study in Hong 
Kong that suggested advanced age and longer duration 
of antihypertensive medication use was independently 
associated with poor BP control.65 The longer dura-
tion of hypertension may indicate poor adherence to 
Total
(n=873)
Men
(n=360)
Women
(n=513)
P value
Mean (SD)/
n (%)
Mean (SD)/
n (%)
Mean (SD)/
n (%)
  Diabetes 91 (10.4) 35 (9.7) 56 (10.9) 0.569
  Arthritis 61 (7.0) 18 (5.0) 43 (8.4) 0.049
  COPD 55 (6.3) 24 (6.7) 31 (6.0) 0.710
  MI 17 (1.9) 10 (2.8) 7 (1.4) 0.141
  Nephropathy 11 (1.3) 7 (1.9) 4 (0.8) 0.132
  Gastrointestinal disease 10 (1.1) 5 (1.4) 5 (1.0) 0.574
  0 401 (45.9) 184 (51.1) 217 (42.3) 0.010
  ≥1 472 (54.1) 176 (48.9) 296 (57.7)
BP control 0.242
  Good control 287 (32.9) 110 (30.6) 177 (34.5)
  Poor control 586 (67.1) 250 (69.4) 336 (65.5)
BMI, body mass index; BP, blood pressure; CAD, coronary artery disease; COPD, chronic obstructive pulmonary disease; MI, myocardial 
infarction; NCMS, New Rural Cooperative Medical Scheme; UEMI, Urban Employees’ Medical Insurance; URMI, Urban Residents’ Medical 
Insurance; WC, waist circumference.
Table 1 Continued 
Table 2 Difference in self-management processes in community participants with hypertension
Total
(n=873)
Men
(n=360)
Women
(n=513)
P valueMean (SD) Mean (SD) Mean (SD)
Treatment management 59.54 (17.43) 59.49 (18.01) 59.58 (17.02) 0.937
Diet management 70.18 (23.36) 67.71 (24.18) 71.91 (22.63) 0.009
Physical exercise management 60.80 (32.69) 59.63 (33.21) 61.62 (32.33) 0.377
Lifestyle management 63.47 (18.38) 64.92 (17.91) 62.45 (18.66) 0.051
Risk factors management 86.91 (24.64) 73.70 (30.53) 96.18 (13.12) <0.001
Total score 65.58 (13.22) 63.61 (14.28) 66.96 (12.25) <0.001
No. of visiting CHC (per year), n (%) 0.060
  0 322 (36.9) 146 (40.6) 176 (34.3)
  ≥1 551 (63.1) 214 (59.4) 337 (65.7)
No. of visiting hospital (per year), n (%) 0.001
  0 653 (74.8) 290 (80.6) 363 (70.8)
  ≥1 220 (25.2) 70 (19.4) 150 (29.2)
CHC, community health centres.
 o
n
 25 M
arch 2019 by guest. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2018-025819 on 20 March 2019. Downloaded from 
7Qu Z, et al. BMJ Open 2019;9:e025819. doi:10.1136/bmjopen-2018-025819
Open access
Ta
b
le
 3
 
Lo
gi
st
ic
 r
eg
re
ss
io
n 
of
 b
lo
od
 p
re
ss
ur
e 
co
nt
ro
l a
m
on
g 
co
m
m
un
ity
 p
ar
tic
ip
an
ts
 w
ith
 h
yp
er
te
ns
io
n
M
o
d
el
 1
M
o
d
el
 2
M
o
d
el
 3
O
R
C
I
P
 v
al
ue
O
R
C
I
P
 v
al
ue
O
R
C
I
P
 v
al
ue
A
ge
 (y
ea
r)
1.
00
0.
98
 t
o 
1.
02
0.
96
5
0.
99
0.
98
 t
o 
1.
01
0.
54
5
1.
00
0.
98
 t
o 
1.
02
0.
60
0
S
ex
 (v
s 
m
al
e)
0.
76
0.
55
 t
o 
1.
03
0.
08
0
0.
85
0.
56
 t
o 
1.
29
0.
44
5
0.
80
0.
52
 t
o 
1.
24
0.
31
4
M
ar
ita
l s
ta
tu
s 
(v
s 
m
ar
rie
d
)
1.
27
0.
80
 t
o 
2.
02
0.
31
9
1.
25
0.
78
 t
o 
2.
01
0.
34
9
1.
20
0.
74
 t
o 
1.
94
0.
47
0
E
d
uc
at
io
n
0.
32
7
0.
46
3
0.
65
2
 
 H
S
 (v
s 
co
lle
ge
)
1.
32
0.
87
 t
o 
1.
99
0.
19
1
1.
28
0.
84
 t
o 
1.
95
0.
24
7
1.
22
0.
79
 t
o 
1.
87
0.
37
8
 
 P
S
 (v
s 
co
lle
ge
)
1.
50
0.
80
 t
o 
2.
80
0.
20
4
1.
37
0.
72
 t
o 
2.
58
0.
33
9
1.
25
0.
65
 t
o 
2.
40
0.
49
6
E
m
p
lo
ym
en
t
0.
16
3
0.
14
8
0.
21
8
 
 U
ne
m
p
lo
ye
d
 (v
s 
em
p
lo
ye
d
)
0.
84
0.
44
 t
o 
1.
64
0.
61
7
0.
87
0.
44
 t
o 
1.
70
0.
67
3
0.
84
0.
42
 t
o 
1.
66
0.
61
1
 
 R
et
ir e
d
 (v
s 
em
p
lo
ye
d
)
0.
65
0.
41
 t
o 
1.
02
0.
06
2
0.
64
0.
40
 t
o 
1.
02
0.
05
9
0.
66
0.
41
 t
o 
1.
06
0.
08
6
In
co
m
e 
(v
s 
>
¥1
50
0)
2.
54
0.
78
 t
o 
8.
33
0.
12
3
2.
68
0.
80
 t
o 
8.
93
0.
10
9
2.
41
0.
71
 t
o 
8.
12
0.
15
7
H
ea
lth
 in
su
ra
nc
e
0.
07
5
0.
08
2
0.
18
2
 
 U
R
M
I (
vs
 U
E
M
I)
1.
13
0.
69
 t
o 
1.
84
0.
62
4
1.
10
0.
67
 t
o 
1.
79
0.
71
7
0.
97
0.
58
 t
o 
1.
63
0.
92
0
 
 N
C
M
S
 (v
s 
U
E
M
I)
2.
70
1.
28
 t
o 
5.
67
0.
00
9
2.
69
1.
27
 t
o 
5.
69
0.
01
0
2.
26
1.
06
 t
o 
4.
81
0.
03
4
 
 U
ni
ns
ur
ed
 (v
s 
 U
E
M
I)
1.
35
0.
55
 t
o 
3.
33
0.
51
6
1.
27
0.
51
 t
o 
3.
16
0.
60
7
1.
14
0.
45
 t
o 
2.
86
0.
78
7
E
d
uc
at
io
n 
×
 in
co
m
e
0.
46
0
0.
42
6
0.
41
0
 
 H
S
 ×
 in
co
m
e 
(<
¥ 
15
00
)
0.
53
0.
15
 t
o 
1.
84
0.
31
9
0.
52
0.
15
 t
o 
1.
84
0.
31
2
0.
54
0.
15
 t
o 
1.
92
0.
33
8
 
 P
S
 ×
 in
co
m
e 
(<
¥ 
15
00
)
0.
78
0.
19
 t
o 
3.
12
0.
72
2
0.
79
0.
19
 t
o 
3.
24
0.
74
5
0.
86
0.
21
 t
o 
3.
56
0.
83
0
B
M
I (
kg
/m
2 )
1.
01
0.
95
 t
o 
1.
06
0.
86
8
1.
00
0.
95
 t
o 
1.
06
0.
97
2
W
C
 (v
s 
no
rm
al
)
1.
14
0.
76
 t
o 
1.
69
0.
53
5
1.
12
0.
75
 t
o 
1.
69
0.
58
5
S
m
ok
in
g 
(v
s 
no
n-
sm
ok
er
)
1.
38
0.
87
 t
o 
2.
21
0.
17
3
1.
52
0.
93
 t
o 
2.
51
0.
09
9
D
rin
ki
ng
 (v
s 
no
-d
rin
ki
ng
)
1.
02
0.
65
 t
o 
1.
62
0.
92
6
0.
95
0.
58
 t
o 
1.
56
0.
83
3
Fa
m
ily
 h
is
to
ry
 (v
s 
no
)
0.
84
0.
62
 t
o 
1.
15
0.
28
3
0.
89
0.
65
 t
o 
1.
23
0.
48
4
D
is
ea
se
 d
ur
at
io
n 
(y
ea
rs
)
1.
03
1.
01
 t
o 
1.
04
0.
00
6
1.
03
1.
01
 t
o 
1.
04
0.
00
8
C
om
or
b
id
iti
es
 (v
s 
no
)
1.
13
0.
83
 t
o 
1.
54
0.
44
3
1.
14
0.
83
 t
o 
1.
56
0.
43
0
Tr
ea
tm
en
t 
m
an
ag
em
en
t
0.
98
0.
97
 t
o 
0.
99
0.
00
0
D
ie
t 
m
an
ag
em
en
t
1.
00
0.
99
 t
o 
1.
01
0.
63
9
P
hy
si
ca
l e
xe
rc
is
e 
m
an
ag
em
en
t
1.
00
0.
99
 t
o 
1.
00
0.
71
1
Li
fe
st
yl
e 
m
an
ag
em
en
t
1.
00
0.
99
 t
o 
1.
01
0.
44
9
R
is
k 
fa
ct
or
 m
an
ag
em
en
t
1.
00
0.
99
 t
o 
1.
01
0.
38
1
N
o.
 o
f v
is
iti
ng
 C
H
C
 (p
er
 y
ea
r)
1.
00
0.
98
 t
o 
1.
03
0.
74
3
N
o.
 o
f v
is
iti
ng
 h
os
p
ita
l (
p
er
 y
ea
r)
0.
99
0.
92
 t
o 
1.
07
0.
80
0
C
on
tin
ue
d
 o
n
 25 M
arch 2019 by guest. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2018-025819 on 20 March 2019. Downloaded from 
8 Qu Z, et al. BMJ Open 2019;9:e025819. doi:10.1136/bmjopen-2018-025819
Open access 
self-management practices. However, others reported 
good adherence and better BP control in elderly individ-
uals (age ≥65 years) with hypertension and a longer dura-
tion of antihypertensive medicine use.66 67 In general, BP 
may be more difficult to control with increasing age. A 
cross-sectional study of outpatients in the USA reported 
that concomitant use of more than one antihyperten-
sive medication increases with patient age (up to age 80 
years, after which it then decreases); this may have an 
impact on the patient’s willingness or ability to comply 
with the overall treatment regimens.68 More than half of 
the participants in this study had more than one comor-
bidity, which may have influenced participants’ medica-
tion adherence.
Women in this study were significantly older and more 
likely to have more than one comorbidity (eg, arthritis 
and back and neck problems) compared with men. In 
addition to age, biological sex influences the development 
of comorbidities,69 70 such as hypertension after meno-
pause.35 Comorbidities among women aged 60–79 years 
with hypertension have been previously reported69 70; 
they increase the complexities of care for women,71 and 
have been associated with poor self-care ability.71 Low 
income has not only been a predictor resulting in low 
adherence to medication regimens,72 it has also been a 
factor associated with the development of the comorbid 
disease.73 More women in this study also lived alone with 
fewer supports compared with men. These findings may 
explain the more frequent unscheduled physician and 
CHC visits in women and provide important information 
for developing effective self-management interventions 
to improve BP control in China.
Individuals in this study with lower personal incomes 
were women; women who were older, lived alone, had 
lower education and were more likely to be unemployed. 
Level of education, hours of work, occupation and respon-
sibility in caring for children has been conceptualised 
by others as gender related.74 Lower educated women 
compared with higher educated women and non-working 
women compared non-working men have been associated 
with poor BP control75 76; others report traditional sex 
differences in CVD risk factors are explained by feminine 
personality traits (ie, gender).40 Neither sex nor gender 
affected BP control in this study, but it may be because 
we did not have a robust measure of gender. Gender has 
generally been defined across four dimensions including 
gender roles, gender identity, gender relationships and 
institutionalised gender.42 The important role gender 
may play in BP control requires further investigation, 
especially in a culture where boys are encouraged to 
pursue higher education and girls encouraged to work in 
the family home.
Process of self-management and bP control
This study is one of few to compare hypertensive 
self-management skills in treatment, diet, physical exer-
cise, lifestyle and risk factors in China. Poor BP control 
was significantly associated with low self-management 
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skills, especially in treatment management (eg, medica-
tion adherence, regularly scheduled doctors’ visits and 
self-monitoring of BP). This is supported by the IFSMT 
theory, which purports successful BP control at the indi-
vidual level is related to an individual’s self-management 
skills and their involvement in the treatment and control 
of their condition.26 A lifelong adherence to prescribed 
antihypertensive medications, regular clinic visits and 
self-monitoring skills have assisted other individuals 
to control their BP.77 78 Non-adherence to treatment 
management is related to a higher risk of cardiovascular 
morbidity and mortality.79 80 Hypertension is an asymp-
tomatic disease, most individuals with hypertension do 
not experience symptoms and may not feel it necessary 
to adhere to prescribed or suggested treatment regi-
mens.81 Moreover, medication side effects may also deter 
individuals from adhering to prescribed or suggested 
treatment regimens, especially in the elderly Chinese.82 
The perceived benefits of Chinese herbs may be more 
important than Western antihypertensive medications 
for elderly Chinese who tend to be less adherent with 
Western antihypertensive medications and believe 
Chinese herbs have fewer side effects.83 Integrating tradi-
tional practices into hypertension management regimens 
with frequent and careful monitoring of side effects and 
adjustment of medications may be warranted. Effective-
ness and adherence to antihypertensive medication regi-
mens depends on regularly scheduled visits to CHC.25 
Regular BP monitoring also reduces hypertension,19 84 
suggesting home BP monitoring should have a primary 
role in long-term BP control in China.
The results of this study also show that women are 
more likely to have better skills in diet and risk factor 
management. The findings are consistent with those of 
Choi et al85 and Zhou et al86 who report that women with 
hypertension have higher diet management skills, espe-
cially related to the daily consumption of fresh vegetables 
and fruits, which are thought to be protective factors asso-
ciated with better BP control.86
Diet and risk factor management were not significantly 
associated with BP control in this study and this may be 
because diet management (eg, balanced diet and salt/
sodium control) is difficult for participants to conceptu-
alise. This requires exploration in a future study.
Limitations: There are several limitations to the study. 
First, this study is cross-sectional and results may be 
subject to a non-response bias.55 There could be other 
unobserved confounding factors we have neither consid-
ered nor controlled. However, recruiting a large number 
of individuals with hypertension across four areas of 
China attempted to minimise this bias. Second, many 
of the context and process variables were self-reported, 
increasing the potential for a response bias. Third, the 
self-management for patients with hypertension scale 
has not been widely used and need further psychometric 
testing. Lastly, a more robust measure of gender needs 
to be incorporated into future research. The strengths 
of the study include the use of the  IFSMT and the 
incorporation of sex and gender-based lens to guide the 
data analyses and interpretation.
COnClusiOn
This is one of few studies using IFSMT theory to assess 
how context and process variables influence self-manage-
ment and BP in individuals with hypertension. Context 
variables related to longer disease duration and NCMS 
health insurance (inadequate outpatient care benefits 
for rural residents) were associated with poor control of 
hypertension in China. Lower cost sharing of outpatient 
care, increasing access to preventive care and improving 
accessibility to medications and self-management strate-
gies for NCMS enrollees should be considered by Chinese 
healthcare policy-makers. Moreover, sex and gender-re-
lated factors including strategies to improve self-man-
agement skills and provide social supports need to be 
investigated in future randomised controlled trials.
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